Stay updated on Intranasal Etripamil Safety Study for PSVT Clinical Trial
Sign up to get notified when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.

Latest updates to the Intranasal Etripamil Safety Study for PSVT Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check8 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check15 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check22 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page has undergone significant content removal regarding the NODE-302 study, including detailed descriptions of the study's objectives, eligibility criteria, and procedures. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference43%
Stay in the know with updates to Intranasal Etripamil Safety Study for PSVT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.